Breaking News
February 16, 2019 - Collaborative material research could advance self-assembling nanomaterials
February 16, 2019 - Researchers take major step in creating technology that mimics the human brain
February 16, 2019 - Erasing memories associated with cocaine use reduces drug seeking behavior
February 16, 2019 - Artificial intelligence can accurately predict prognosis of ovarian cancer patients
February 16, 2019 - Racial disparities in cancer deaths on the decline for America
February 16, 2019 - FDA authorizes new interoperable insulin pump for children, adults with diabetes
February 16, 2019 - Coexisting Medical Conditions, Smoking Explain PTSD-CVD Link
February 16, 2019 - Skin Cancer Screening: MedlinePlus Lab Test Information
February 16, 2019 - ‘Happiness’ exercises can boost mood in those recovering from substance use disorder
February 16, 2019 - Cell manipulation could soon halt or reverse aging
February 16, 2019 - Pumped Breast Milk Falls Short of Breastfed Version
February 16, 2019 - Men’s porn habits could fuel partners’ eating disorders, study suggests
February 16, 2019 - Rapid progression of age-related diseases may result from formation of vicious cycles
February 16, 2019 - Immune checkpoint molecule protects against future development of cancer
February 16, 2019 - New method produces hydrogels that have properties similar to cells’ environment
February 16, 2019 - $4.1 million funding for heart research on Valentine’s Day
February 16, 2019 - General anesthesia in early infancy unlikely to have lasting effects on developing brains
February 16, 2019 - New breakthroughs for muscular dystrophy research
February 16, 2019 - First Opinion: Embryo editing for higher IQ is a fantasy. Embryo profiling for it is almost here
February 16, 2019 - Vapers develop cancer-related gene deregulation as cigarette smokers
February 16, 2019 - Bringing Antimicrobial Susceptibility Testing (AST) to the Community
February 16, 2019 - Decolonization protocol after hospital discharge can prevent dangerous infections
February 16, 2019 - New technique using patients’ own modified cells could help treat Crohn’s disease
February 16, 2019 - Therapeutic endoscopy has an expanding role in the treatment of IBD
February 16, 2019 - Blood clot discovery could lead to development of better treatments for blood diseases
February 16, 2019 - Intervention can increase exclusive breastfeeding rates
February 16, 2019 - New project explores how gaming technologies can help cancer patients communicate better
February 16, 2019 - Catalyst Biosciences Presents Updated Data from Its Phase 2/3 Trial of Subcutaneous Marzeptacog Alfa (Activated) in Individuals with Hemophilia A or B with Inhibitors at the 12th Annual EAHAD Congress
February 16, 2019 - Rerouting nerves during amputation reduces phantom limb pain before it starts
February 16, 2019 - A Hormone Produced When We Exercise Might Help Fight Alzheimer’s
February 16, 2019 - Millions of British people breathe toxic air travelling to GPs
February 16, 2019 - Conformance of genetic characteristics found to be crucial for longer preservation of kidney graft
February 16, 2019 - Researchers use optogenetic tool to control, visualize receptor signals in neural cells
February 16, 2019 - New reversible antiplatelet therapy could reduce risk of blood clots, prevent cancer metastasis
February 16, 2019 - Testosterone is not the only hormone needed for penis development
February 16, 2019 - FDA Advisory Committee Recommends Approval of Spravato (esketamine) Nasal Spray for Adults with Treatment-Resistant Depression
February 15, 2019 - Heart surgery technology developed at Baptist Health debuts after years of secrecy
February 15, 2019 - Prescription Opioids Double Risk of Triggering Fatal Car Crash
February 15, 2019 - New study helps doctors better understand high blood pressure in pregnant women
February 15, 2019 - Beta wave control in Parkinson’s diseased brain could be a potential therapy
February 15, 2019 - Media representations of love may justify gender-based violence in young people
February 15, 2019 - Yoga May Help With Rheumatoid Arthritis Symptoms, Severity
February 15, 2019 - Obstructive sleep apnea linked to inflammation, organ dysfunction
February 15, 2019 - Master your mind: A challenge from WELL for Life
February 15, 2019 - Why Some Brain Tumors Respond to Immunotherapy
February 15, 2019 - Must-Reads Of The Week From Brianna Labuskes
February 15, 2019 - Researchers uncover novel mechanism and potential new therapeutic target for Alzheimer’s
February 15, 2019 - Genetic variations in a fourth gene associated with higher ALL risk in Hispanic children
February 15, 2019 - Disruptive behavioral problems in kindergarten linked with lower employment earnings in adulthood
February 15, 2019 - New bioengineered device enhances the production of T-cells
February 15, 2019 - HDL proteome behaves like a tiny Velcro ball that is rolling on surfaces
February 15, 2019 - Puerto Rican children more likely to have poor or decreasing use of asthma inhalers
February 15, 2019 - Quality of patient care does not improve after physician-hospital integration
February 15, 2019 - Synopsys release new software for implant design and patient-specific planning
February 15, 2019 - 6 out of 10 hip replacements last 25 years or longer
February 15, 2019 - Health Tip: What You Should Know About Antibiotics
February 15, 2019 - New research challenges medical consensus that adenoids and tonsils significantly shrink during teenage years
February 15, 2019 - Discovery of weakness in a rare cancer could be exploited with drugs
February 15, 2019 - UVA scientists find potential explanation for mysterious cell death in Alzheimer’s, Parkinson’s
February 15, 2019 - New rules requiring female athletes to lower testosterone levels are based on flawed data
February 15, 2019 - Researchers comprehensively sequence the human immune system
February 15, 2019 - Researchers study animal venoms to identify new medicines for treating diseases
February 15, 2019 - Movement of wrist bones revealed by MRI and computer modeling
February 15, 2019 - Philips introduces new premium digital X-ray room to help shorten patient wait times
February 15, 2019 - Women fare worse than men following aortic heart surgery, study finds
February 15, 2019 - High-protein and low-calorie diet helps older adults lose weight safely, shows study
February 15, 2019 - Drug microdosing effects may not measure up to big expectations
February 15, 2019 - Discharged, Dismissed: ERs Often Miss Chance To Set Overdose Survivors On ‘Better Path’
February 15, 2019 - A digitized lab environment to be showcased at smartLAB 2019
February 15, 2019 - Scientists uncover main mechanisms of fluconazole drug resistance
February 15, 2019 - New study seeks to understand how colibactin causes cancer
February 15, 2019 - Photoacoustic imaging accurately measures the temperature of deep tissues
February 15, 2019 - Large study finds no association between phthalate exposure and breast cancer risk
February 15, 2019 - New research explains presence of ‘natural’ magnetism in human cells
February 15, 2019 - Bio-Rad launches new digital PCR system and kit for monitoring treatment response in CML patients
February 15, 2019 - Excessive daytime sleepiness in OSA patients linked to greater risk for cardiovascular diseases
February 15, 2019 - Scientists shed light on damaging cell effects linked to aging
February 15, 2019 - Celiac disease may be caused by stomach bug in childhood
February 15, 2019 - NHS performance figures highlight the true scale of Emergency Department crisis
February 15, 2019 - High intensity exercise may improve health by increasing gut microbiota diversity
ALS and Tow Foundation announce their continuing support to New York Genome Center

ALS and Tow Foundation announce their continuing support to New York Genome Center

image_pdfDownload PDFimage_print

The ALS Association and The Tow Foundation are pleased to announce their continuing support of the New York Genome Center’s (NYGC) Center for Genomics of Neurodegenerative Disease (CGND), in recognition of the substantial genomic research being carried out by NYGC scientists. The ALS Association has committed an additional $3.5 million to the NYGC’s CGND, including a $1 million commitment from the Association’s Greater New York Chapter. The Tow Foundation in New Canaan, CT, has contributed an additional $2.5 million gift.

Following the ALS Ice Bucket Challenge in 2014, The ALS Association invested $2.5 million in the CGND to match a $2.5 million gift from The Tow Foundation. The success of this unique three-way partnership between The ALS Association, The Tow Foundation and CGND in advancing research to develop new ALS treatments has resulted in this renewed support and commitment of nearly $6 million in additional funding. To date, the joint gift to the NYGC CGND has contributed to sequencing and analyzing thousands of ALS genomic samples, while pairing this information with patient clinical history. This data has led to better understanding of ALS disease pathways and supported many new ALS gene discoveries using cutting-edge genomic technology and disease models. Through initiating and fostering many critical collaborations, ALS data sharing increased on a large scale, empowering an integrative worldwide approach to find effective treatments and a cure for ALS. Funding by The ALS Association will further the work of the CGND, led by its Director, Hemali Phatnani, PhD, as it combines the expertise of NYGC scientists and its global partners to translate its genomic research into innovative advancements in clinical care and accelerate the development of new ALS treatments.

“The ALS Association is proud to continue our support for the critical work the NYGC CGND is doing to reveal genomic patterns and pathways that help us better understand the complexities of ALS,” stated Calaneet Balas, President and CEO of the Association. “NYGC CGND has helped create a flourishing ALS big data community focused on innovation and open data sharing. We look forward to seeing the many new discoveries that it will continue to generate.”

“We are very grateful to The ALS Association and the Tow Foundation’s ongoing support of our genomic research to discover new mutations and elucidate the mechanisms underlying ALS,” said Tom Maniatis, PhD, NYGC’s Scientific Director and CEO.

Since its inception, NYGC’s CGND has established itself as a prominent player in ALS genetics, leading the way in ALS gene discovery. It represents an important hub of ALS data collection and analysis, which fosters an ever-growing array of collaborative partnerships within the ALS community. The CGND’s ALS Consortium, a collaboration of clinicians, scientists, geneticists and computational biologists, has grown to 29 member institutions from around the globe. The data accumulated is shared at an unparalleled scale with ALS researchers globally, empowering an integrated worldwide approach to working toward effective therapies and a cure for ALS.

At the CGND, the goal is to sequence and analyze the genomes of several thousand clinically well-annotated ALS patient samples. Researchers utilize state-of-the-art clinical and functional genomics techniques and bioinformatics to discover new ALS genes, which represent new therapeutic targets and lead to a better understanding of ALS disease pathways.

Its pioneering work includes sequencing genomes and analyzing data from 1,000 ALS patients collected through Answer ALS, which is openly shared with the global ALS research community. This new investment by The ALS Association includes $450,000 in funding toward completing this massive whole genome sequencing effort, which continues its support and collaboration with Answer ALS.

Source:

https://www.nygenome.org/news/the-als-association-and-the-tow-foundation-commit-additional-6-million-to-new-york-genome-center/

Tagged with:

About author

Related Articles